May 9, 2019
Related News
Other posts that you should not miss.
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the …
June 3, 2019
Dr David Ribeiro, CEO of ProAxsis, will be attending the Anglonordic Life Sciences Conference, taking place in London …
May 30, 2017
Dr David Ribeiro, CEO of ProAxsis, will be attending the 10th anniversary Biotrinity conference, taking place in London on …
April 19, 2016
